Crunching the numbers for DHR... Refresh in a moment for the full analysis.
DANAHER CORP /DE/ (DHR)
Healthcare
Fairly Valued
mixed
$192.39
Updated: 2026-04-09
Financial Strength
45
Mixed
Capital Allocation
60
Healthy
Fair Value
$13.28
DCF Upside
-93.1%
Sector Rank
#6
of 18
Key Findings
+
Historically cheap — EV/EBITDA in bottom 25% of its 5-year range
−
High leverage — net debt/EBITDA between 3× and 5×
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.